Active ingredients: letrozole
What it is used for
Treatment of postmenopausal women with hormone receptor positive breast cancer (see "Clinical Trials"). The safety and efficacy of neoadjuvant use has not been established. Letrozole is not indicated in hormone receptor negative disease.
How to take it
The way to take this medicine is: Oral. This medicine is taken by mouth.
- Store below 30 degrees Celsius
- Protect from Moisture
- Shelf lifetime is 3 Years.
Always read the label. If symptoms persist see your healthcare professional.
Yellow to dark yellow round, film coated, biconvex tablet engraved with ' L' on one face and plain on the other
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Is this medicine subsidised?
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on November 1, 2019. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy?
For the active ingredient letrozole
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems